Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| NOVAVAX INC | 68,061 | reported | 07 Mar 2025 | tx 355+3,724,273−573,844.01 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 07 Mar 2025 | TAX_WITHHOLDING | NOVAVAX INC | 13,954 | 8.34 USD | |
| 07 Mar 2025 | EXERCISE | NOVAVAX INC | 28,890 | 0.00 USD | |
| 07 Mar 2025 | EXERCISE | NOVAVAX INC | 28,890 | 0.00 USD | deriv |
| 01 Mar 2025 | EXERCISE | NOVAVAX INC | 48,000 | 0.00 USD | |
| 01 Mar 2025 | TAX_WITHHOLDING | NOVAVAX INC | 23,185 | 8.33 USD | |
| 01 Mar 2025 | EXERCISE | NOVAVAX INC | 48,000 | 0.00 USD | deriv |
| 19 Aug 2024 | TAX_WITHHOLDING | NOVAVAX INC | 317 | 13.90 USD | |
| 19 Aug 2024 | EXERCISE | NOVAVAX INC | 655 | 0.00 USD | |
| 19 Aug 2024 | EXERCISE | NOVAVAX INC | 655 | 0.00 USD | deriv |
| 01 Mar 2024 | GRANT_AWARD | NOVAVAX INC | 144,000 | 0.00 USD | deriv |
| 10 Mar 2024 | EXERCISE | NOVAVAX INC | 4,608 | — | |
| 10 Mar 2024 | TAX_WITHHOLDING | NOVAVAX INC | 2,226 | 5.45 USD | |
| 10 Mar 2024 | EXERCISE | NOVAVAX INC | 4,608 | 0.00 USD | deriv |
| 07 Mar 2024 | TAX_WITHHOLDING | NOVAVAX INC | 13,955 | 5.61 USD | |
| 07 Mar 2024 | EXERCISE | NOVAVAX INC | 28,890 | — | |
| 07 Mar 2024 | EXERCISE | NOVAVAX INC | 28,890 | 0.00 USD | deriv |
| 14 Dec 2023 | TAX_WITHHOLDING | NOVAVAX INC | 773 | 5.69 USD | |
| 14 Dec 2023 | EXERCISE | NOVAVAX INC | 1,600 | — | |
| 14 Dec 2023 | EXERCISE | NOVAVAX INC | 1,600 | 0.00 USD | deriv |
| 19 Aug 2023 | TAX_WITHHOLDING | NOVAVAX INC | 317 | 7.14 USD | |
| 19 Aug 2023 | EXERCISE | NOVAVAX INC | 655 | — | |
| 19 Aug 2023 | EXERCISE | NOVAVAX INC | 655 | 0.00 USD | deriv |
| 25 Jun 2023 | TAX_WITHHOLDING | NOVAVAX INC | 403 | 6.70 USD | |
| 25 Jun 2023 | EXERCISE | NOVAVAX INC | 833 | — | |
| 25 Jun 2023 | EXERCISE | NOVAVAX INC | 833 | 0.00 USD | deriv |
2 purchases reported after at least 12 months of silence — most recent on 14 May 2018.